Abstract
Phylodynamic techniques combine epidemiological and genetic information to analyze the evolutionary and spatiotemporal dynamics of rapidly evolving pathogens, such as influenza A or human immunodeficiency viruses. We introduce allele dynamics plots (AD-plots) as a method for visualizing the evolutionary dynamics of a gene in a population. Using AD-plots, we propose to identify the alleles that are likely to be subject to directional selection. We analyze the method’s merits with a detailed study of the evolutionary dynamics of seasonal influenza A viruses. AD-plots for the major surface protein of seasonal influenza A (H3N2) and the 2009 swine-origin influenza A (H1N1) viruses show the succession of substitutions that became fixed in the evolution of the two viral populations. They also allow the early identification of those viral strains that later rise to predominance, which is important for the problem of vaccine strain selection. In summary, we describe a technique that reveals the evolutionary dynamics of a rapidly evolving population and allows us to identify alleles and associated genetic changes that might be under directional selection. The method can be applied for the study of influenza A viruses and other rapidly evolving species or viruses.
Adapted from: Steinbrück L, McHardy AC (2011) Allele dynamics plots for the study of evolutionary dynamics in viral populations. Nucleic Acids Res 39(1):e4, by permission of Oxford University Press.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM, Mumford JA, Holmes EC (2004) Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303:327–332
Pybus OG, Rambaut A (2009) Evolutionary analysis of the dynamics of viral infectious disease. Nat Rev Genet 10:540–550
Wallace RG, HoDac HM, Lathrop RH, Fitch WM (2007) A statistical phylogeography of influenza A H5N1. Proc Natl Acad Sci U S A 104:4473–4478
Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F et al (2006) Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 313:523–526
Lemey P, Pybus OG, Wang B, Saksena NK, Salemi M, Vandamme A-M (2003) Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci U S A 100:6588–6592
Bush R (1999) Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 16:1457–1465
Kryazhimskiy S, Plotkin JB (2008) The population genetics of dN/dS. PLoS Genet 4:e1000304
Pond SLK, Frost SDW, Muse SV (2005) HyPhy: hypothesis testing using phylogenies. Bioinformatics 21:676–679
Pond K, Sergei L, Poon AFY, Brown L, Andrew J, Frost SDW (2008) A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. Mol Biol Evol 25:1809–1824
Ricklefs RE (2007) Estimating diversification rates from phylogenetic information. Trends Ecol Evol 22:601–610
Koelle K, Cobey S, Grenfell B, Pascual M (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314:1898–1903
Fouchier RAM, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus ADME (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79:2814–2822
WHO (2009) Recommended composition of influenza virus vaccines for use in 2009–2010 influenza season (northern hemisphere winter). Wkly Epidemiol Rec 84:65–72
WHO (2010) Recommended viruses for influenza vaccines for use in the 2010–2011 northern hemisphere influenza season. Wkly Epidemiol Rec 85:81–92
Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus ADME, Fouchier RAM (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305:371–376
Wiley D, Wilson I, Skehel J (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373–378
Wiley DC, Skehel JJ (1987) The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56:365–394
Wilson IA, Cox NJ (1990) Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8:737–771
Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531–569
Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT (2006) Host species barriers to influenza virus infections. Science 312:394–397
Webster R, Bean W, Gorman O, Chambers T, Kawaoka Y (1992) Evolution and ecology of influenza A viruses. Microbiol Rev 56:152–179
Lowen AC, Palese P (2007) Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. Infect Disord Drug Targets 7:318–328
Morens DM, Taubenberger JK, Fauci AS (2009) The persistent legacy of the 1918 influenza virus. N Engl J Med 361:225–229
Neumann G, Noda T, Kawaoka Y (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931–939
Zimmer SM, Burke DS (2009) Historical perspective – emergence of influenza A (H1N1) viruses. N Engl J Med 361:279–285
Cox NJ, Brammer TL, Regnery HL (1994) Influenza: global surveillance for epidemic and pandemic variants. Eur J Epidemiol 10:467–470
Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC et al (2008) Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine 26:31–34
Nelson MI, Simonsen L, Viboud C, Miller MA, Holmes EC, Levin B (2007) Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog 3:e131
Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC et al (2008) The global circulation of seasonal influenza A (H3N2) viruses. Science 320:340–346
Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, Holmes EC (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453:615–619
Shih ACC, Hsiao TC, Ho MS, Li WH (2007) Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A 104:6283–6288
Plotkin JB, Dushoff J, Levin SA (2002) Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A 99:6263–6268
Du X, Wang Z, Wu A, Song L, Cao Y, Hang H, Jiang T (2008) Networks of genomic co-occurrence capture characteristics of human influenza A (H3N2) evolution. Genome Res 18:178–187
Xia Z, Jin G, Zhu J, Zhou R (2009) Using a mutual information-based site transition network to map the genetic evolution of influenza A/H3N2 virus. Bioinformatics 25:2309–2317
Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM (1999) Predicting the evolution of human influenza A. Science 286:1921–1925
Nozawa M, Suzuki Y, Nei M (2009) Reliabilities of identifying positive selection by the branch-site and the site-prediction methods. Proc Natl Acad Sci U S A 106:6700–6705
Fouchier RAM, Smith DJ (2010) Use of antigenic cartography in vaccine seed strain selection. Avian Dis 54:220–223
Huang JW, King CC, Yang JM (2009) Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics 10:S41
Lee MS, Chen MC, Liao YC, Hsiung CA (2007) Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine 25:8133–8139
Liao YC, Lee MS, Ko CY, Hsiung CA (2008) Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics 24:505–512
Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82:596–601
Edgar RC (2004) MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 5:113
Guindon S, Gascuel O (2003) A simple, fast, and accurate method to estimate large phylogenies by maximum likelihood. Syst Biol 52:696–704
Zwickl D (2006) Genetic algorithm approaches for the phylogenetic analysis of large biological sequence datasets under the maximum likelihood criterion. Thesis, The University of Texas at Austin
Futuyma DJ (1998) Evolutionary biology, 3rd edn. Sinauer Associates, Sunderland, MA
Hein J, Schierup M, Wiuf C (2005) Gene genealogies, variation and evolution: a primer in coalescent theory. Oxford University Press, USA
Templeton AR (2006) Population genetics and microevolutionary theory. Wiley, Hoboken, NJ
Huelsenbeck JP, Ronquist F (2001) MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17:754–755
Drummond A, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7:214
Fitch WM (1971) Toward defining the course of evolution: minimum change for a specific tree topology. Syst Zool 20:406–416
Felsenstein J (2004) Inferring phylogenies. Sinauer Associates, Sunderland, MA
Pagel M, Meade A, Barker D (2004) Bayesian estimation of ancestral character states on phylogenies. Syst Biol 53:673–684
Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nat Rev Genet 8:196–205
Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, Subbu V, Spiro DJ, Sitz J, Koo H, Bolotov P et al (2005) Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 437:1162–1166
WHO (1999) Recommended composition of influenza virus vaccines for use in the 2000 influenza season. Wkly Epidemiol Rec 74:321–325
WHO (2000) Recommended composition of influenza virus vaccines for use in the 2000–2001 season. Wkly Epidemiol Rec 75:61–65
WHO (2001) Recommended composition of influenza virus vaccines for use in the 2001–2002 influenza season. Wkly Epidemiol Rec 76:58–61
WHO (2002) Recommended composition of influenza virus vaccines for use in the 2002–2003 influenza season. Wkly Epidemiol Rec 77:62–66
Lin Y, Gregory V, Bennett M, Hay A (2004) Recent changes among human influenza viruses. Virus Res 103:47–52
Hay AJ, Lin YP, Gregory V, Bennet M (2003) WHO collaborating centre for reference and research on influenza, annual report. National Institute for Medical Research, London
Hay AJ, Lin YP, Gregory V, Bennet M (2005) WHO collaborating centre for reference and research on influenza, interim report February. National Institute for Medical Research, London
Hay AJ, Lin YP, Gregory V, Bennet M (2006) WHO collaborating centre for reference and research on influenza, interim report March. National Institute for Medical Research, London
Hay AJ, Daniels R, Lin YP, Xiang Z, Gregory V, Bennet M, Whittaker L (2007) WHO collaborating centre for reference and research on influenza, interim report September. National Institute for Medical Research, London
WHO (2000) Recommended composition of influenza virus vaccines for use in the 2001 influenza season. Wkly Epidemiol Rec 75:330–333
WHO (2001) Recommended composition of influenza virus vaccines for use in the 2002 influenza season. Wkly Epidemiol Rec 76:311–314
WHO (2002) Recommended composition of influenza virus vaccines for use in the 2003 influenza season. Wkly Epidemiol Rec 77:344–348
WHO (2003) Recommended composition of influenza virus vaccines for use in the 2003–2004 influenza season. Wkly Epidemiol Rec 78:58–62
WHO (2003) Recommended composition of influenza virus vaccines for use in the 2004 influenza season. Wkly Epidemiol Rec 78:375–379
WHO (2004) Recommended composition of influenza virus vaccines for use in the 2004–2005 influenza season. Wkly Epidemiol Rec 79:88–92
WHO (2004) Recommended composition of influenza virus vaccines for use in the 2005 influenza season. Wkly Epidemiol Rec 79:369–373
WHO (2005) Recommended composition of influenza virus vaccines for use in the 2005–2006 influenza season. Wkly Epidemiol Rec 80:66–71
Jin H, Zhou H, Liu H, Chan W, Adhikary L, Mahmood K, Lee MS, Kemble G (2005) Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 336:113–119
WHO (2005) Recommended composition of influenza virus vaccines for use in the 2006 influenza season. Wkly Epidemiol Rec 80:342–347
WHO (2006) Recommended composition of influenza virus vaccines for use in the 2007 influenza season. Wkly Epidemiol Rec 81:390–395
WHO (2007) Recommended composition of influenza virus vaccines for use in the 2007–2008 influenza season. Wkly Epidemiol Rec 82:69–74
WHO (2006) Recommended composition of influenza virus vaccines for use in the 2006–2007 influenza season. Wkly Epidemiol Rec 81:82–86
WHO (2007) Recommended composition of influenza virus vaccines for use in the 2008 influenza season. Wkly Epidemiol Rec 82:351–356
WHO (2008) Recommended composition of influenza virus vaccines for use in the 2008–2009 influenza season. Wkly Epidemiol Rec 83:81–87
WHO (2008) Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season. Wkly Epidemiol Rec 83:366–372
WHO (1999) Recommended composition of influenza virus vaccines for use in the 1999–2000 season. Wkly Epidemiol Rec 74:57–61
Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325:197–201
Smith G, Vijaykrishna D, Bahl J, Lycett S, Worobey M, Pybus O, Ma S, Cheung C, Raghwani J, Bhatt S et al (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122–1125
A Novel Swine-Origin Influenza (H1N1) Virus Investigation Team (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360:2605–2615
Fereidouni SR, Beer M, Vahlenkamp T, Starick E (2009) Differentiation of two distinct clusters among currently circulating influenza A (H1N1)v viruses, March–September 2009. Euro Surveill 14:19409–19411
Pan C, Cheung B, Tan S, Li C, Li L, Liu S, Jiang S (2010) Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus. PLoS One 5:e9549
Nobusawa E, Aoyama T, Kato H, Suzuki Y, Tateno Y, Nakajima K (1991) Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182:475–485
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Steinbrück, L., McHardy, A.C. (2013). Evaluating the Evolutionary Dynamics of Viral Populations. In: Sree Hari Rao, V., Durvasula, R. (eds) Dynamic Models of Infectious Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9224-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9224-5_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9223-8
Online ISBN: 978-1-4614-9224-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)